Company Overview
Snapshot
Founded in December 2014 by Hezkiah Tsoory, iRen Medical operates with 1–10 employees. The company has raised $4.76 million across 5 funding rounds from 8 investors. In January 2023, iRen Medical received FDA regulatory clearance for its digital dialysis system.
Business overview
iRen Medical is dedicated to enhancing the lives of dialysis patients by developing portable peritoneal dialysis systems. The company's core innovation focuses on providing a safe, patient-friendly, and portable solution that allows individuals to undergo dialysis while maintaining their regular activities. This technology also aims to optimize economic models for clinics, improve service quality, and lower costs, creating a comprehensive platform for kidney disease patients and caregivers. iRen Medical operates within the Health Tech & Life Sciences sector, specifically in Medical Devices, Medical Treatment & Therapeutics, Digital Healthcare, and Patient Remote Monitoring.
Strategic signal
In January 2023, iRen Medical secured FDA regulatory clearance for its digital dialysis system. This clearance is a significant validation of the company's technology, indicating its readiness for broader market adoption and potential to disrupt traditional dialysis treatment by enabling more flexible, home-based care. For investors, this signals a critical de-risking event and a clear path to commercialization in the US market, positioning iRen Medical for substantial growth and impact in the digital healthcare and medical device sectors.
Log in to access full profile ›Company Intelligence Q&A
- What was a key regulatory milestone for iRen Medical?
- In January 2023, iRen Medical received FDA regulatory clearance for its digital dialysis system, a significant step towards commercialization.
- When was iRen Medical founded and by whom?
- iRen Medical was founded in December 2014 by Hezkiah Tsoory, who serves as the CEO.
- What is iRen Medical's primary focus?
- iRen Medical focuses on developing portable peritoneal dialysis systems to free patients from traditional dialysis constraints, enabling them to maintain regular activities while undergoing treatment.